[1] FANSANO A.Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin[J].Ann N Y Acad Sci,2000,915:214-222.
[2] WANG W,UZZAU S,GOLDBLUM S E,et al.Human zonulin,a potential modulator of intestinal tight junctions[J].J Cell Sci,2000,113(24):4435-4440.
[3] TRIPATHI A,LAMMERS K M,GOLDBLUM S,et al.Identification of human zonulin,a physiological modulator of tight junctions,as prehatoglobin-2[J].Proc Natl Acad Sci U S A,2009,106(39):16799-16804.
[4] FANSANO A,FIORENTINI C,DONELLI G,et al.Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization,in vitro[J].J Clin Invest,1995,96(2):710-720.
[5] FANSANO A.Intestinal zonulin:open sesame![J].Gut,2001,49(2):159-162.
[6] ASMER R E,PANINGRAHI P,BAMFORD P,et al.Zonulin is involved in the impairment of the gut barrier function following small intestinal bacterial colonization[J].Gastroenterology,2000,118(4):A815.
[7] EL A R,PANIGRAHI P,BAMFORD P,et al.Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure[J].Gastroenterology,2002,123(5):1607-1615.
[8] FANSANO A.Physiological,pathological,and therapeutic implications of zonulin-mediated intestinal barrier modulation[J].Am J Pathol,2008,173(5):1243-1252.
[9] LAMMERS K M,LU R,BROWNLEY J,et al.Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3[J].Gastroenterology,2008,135(1):194-204.
[10] BASKHED F,DING H,WANG T,et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl Acad Sci U S A,2004,101(44):15718-15723.
[11] OLSZANECKA-GLINIANOWICZ M,ZAHORSKA-MARKIEWICZ B,JANOWSJA J,et al.Serum concentrations of nitric oxide,tumor necrosis factor(TNF) alpha and TNF soluble receptors in women with overweight and obesity[J].Metabolism,2004,53(10):1268-1273.
[12] ZAHORSKA-MARKIEWICZ B,JANOWSJA J,OLSZANECKA-GLINIANOWICZ M,et al.Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity[J].Int J Obes Relat Metab Disord,2000,24(11):1392-1395.
[13] ARRIETA M C,BISTRITZ L,MEDDINGS J B.Alterations in intestinal permeability[J].Gut,2006,55(10):1512-1520.
[14] CANI P D,BIBILONI R,KNAUF C,et al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice[J].Diabetes,2008,57(6):1470-1481.
[15] MORENE-NAVARRETE J M,SABATER M,ORTEGA F,et al.Circulating zonulin,a marker of intestinal permeability,is increased in association with obesity-associated insulin resistance[J].PLoS One,2012,7(5):e37160.
[16] BROCK M,TRENKMANN M,GAY R E,et al.MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes[J].J Biol Chem,2011,286(46):40142-40150.
[17] ZHANG D,ZHANG L,ZHENG Y,et al.Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients[J].Diabetes Res Clin Pract,2014,106(2):312-318.
[18] ŻAK-GOŁĄB A,KOCELAK P,APTEKORZ M,et al.Gut microbiota,microinflammation,metabolic profile,and zonulin concentration in obese and normal weight subjects[J].Int J Endocrinol,2013,2013:674106.
[19] KVME T,ACAR S,TUHAN H,et al.The relationship between serum zonulin level and clinical and laboratory parameters of childhood obesity[J].J Clin Res Pediatr E,2017,9(1):31-38.
[20] VAARALA O.Leaking gut in type 1 diabetes[J].Curr Opin Gastroenterol,2008,24(6):701-706.
[21] WATTS T,BERTI I,SAPONE A,et al.Role of the intestinal tight junction modulator zonulin in the pathogenesis of type Ⅰ diabetes in BB diabetic-prone rats[J].Proc Natl Acad Sci U S A,2005,102(8):2916-2921.
[22] VISSER J,BRUGMAN S,KLATTER F,et al.Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat[J].Metabolism,2003,52(3):333-337.
[23] SAPONE A,de MAGISTRIS L,PIETZAK M,et al.Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives[J].Diabetes,2006,55(5):1443-1449.
[24] JAYASHREE B,BIBIN Y S,PRABHU D,et al.Increased circulatory levels of lipopolysaccharide(LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes[J].Mol Cell Biochem,2014,388(1-2):203-210.
[25] CHALASANI N,YOUNOSSI Z,LAVINE J E,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J].Gastroenterology,2012,142(7):1592-1609.
[26] GANGARAPU V,YILDIZ K,INCE A T,et al.Role of gut microbiota:obesity and NAFLD[J].Turk J Gastroenterol,2014,25(2):133-140.
[27] MIELE L,VALENZA V,LA TORRE G,et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J].Hepatology,2009,49(6):1877-1887.
[28] PACIFICO L,BONCI E,MARANDOLA L,et al.Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease[J].World J Gastroenterol,2014,20(45):17107-17114.
[29] HENDY O M,ELSABAAWY M M,AREF M M,et al.Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease[J].APMIS,2017,125(7):607-613.
[30] LI C,GAO M,ZHANG W,et al.Zonulin regulates intestinal permeability and facilitates enteric bacteria permeation in coronary artery disease[J].Sci Rep,2016,6:29142. |
